Filing Details

Accession Number:
0001209191-23-021956
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-31 21:00:16
Reporting Period:
2023-03-30
Accepted Time:
2023-03-31 21:00:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1630627 Treace Medical Concepts Inc. TMCI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1210226 W Richard Mott C/O Treace Medical Concepts, Inc.
100 Palmetto Park Place
Ponte Vedra FL 32081
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-03-30 38,498 $26.00 1,020,000 No 4 S Direct
Common Stock Disposition 2023-03-31 95,000 $25.36 925,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.000 to $26.0200 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. Includes 2,295 RSUs.
  4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.0000 to $25.9050 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.